1. Home
  2. MESO vs UPWK Comparison

MESO vs UPWK Comparison

Compare MESO & UPWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MESO
  • UPWK
  • Stock Information
  • Founded
  • MESO 2004
  • UPWK 2013
  • Country
  • MESO Australia
  • UPWK United States
  • Employees
  • MESO N/A
  • UPWK N/A
  • Industry
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • UPWK EDP Services
  • Sector
  • MESO Health Care
  • UPWK Technology
  • Exchange
  • MESO Nasdaq
  • UPWK Nasdaq
  • Market Cap
  • MESO 2.0B
  • UPWK 2.3B
  • IPO Year
  • MESO N/A
  • UPWK 2018
  • Fundamental
  • Price
  • MESO $16.37
  • UPWK $15.63
  • Analyst Decision
  • MESO Buy
  • UPWK Strong Buy
  • Analyst Count
  • MESO 4
  • UPWK 12
  • Target Price
  • MESO $18.00
  • UPWK $18.83
  • AVG Volume (30 Days)
  • MESO 255.7K
  • UPWK 3.1M
  • Earning Date
  • MESO 03-04-2025
  • UPWK 02-12-2025
  • Dividend Yield
  • MESO N/A
  • UPWK N/A
  • EPS Growth
  • MESO N/A
  • UPWK 2286.76
  • EPS
  • MESO N/A
  • UPWK 1.52
  • Revenue
  • MESO $5,902,000.00
  • UPWK $769,325,000.00
  • Revenue This Year
  • MESO $140.44
  • UPWK $2.09
  • Revenue Next Year
  • MESO $318.31
  • UPWK $7.71
  • P/E Ratio
  • MESO N/A
  • UPWK $10.27
  • Revenue Growth
  • MESO N/A
  • UPWK 11.64
  • 52 Week Low
  • MESO $1.91
  • UPWK $8.43
  • 52 Week High
  • MESO $22.00
  • UPWK $18.14
  • Technical
  • Relative Strength Index (RSI)
  • MESO 39.05
  • UPWK 45.54
  • Support Level
  • MESO $18.00
  • UPWK $15.77
  • Resistance Level
  • MESO $18.49
  • UPWK $18.08
  • Average True Range (ATR)
  • MESO 0.82
  • UPWK 0.78
  • MACD
  • MESO -0.41
  • UPWK 0.07
  • Stochastic Oscillator
  • MESO 1.75
  • UPWK 26.43

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

About UPWK Upwork Inc.

Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to clients.

Share on Social Networks: